Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- RBC Capital analyst Brian Abrahams upgraded Sage Therapeutics, Inc. (NASDAQ:SAGE) from Underperform to Sector Perform and maintained the price target of $4. Sage Therapeutics shares closed at $4.91 on Wednesday. See how other analysts view this stock.
- Morgan Stanley analyst James Faucette upgraded the rating for EVERTEC, Inc. (NYSE:EVTC) from Underweight to Equal-Weight and raised the price target from $33 to $35. Evertec shares closed at $34.84 on Wednesday. See how other analysts view this stock.
- Citigroup analyst Spiro Dounis upgraded DT Midstream, Inc. (NYSE:DTM) from Neutral to Buy and raised the price target from $90 to $115. DT Midstream shares closed at $102.73 on Wednesday. See how other analysts view this stock.
- Rosenblatt analyst Catharine Trebnick upgraded Palo Alto Networks, Inc. (NASDAQ:PANW) from Neutral to Buy and boosted the price target from $390 to $425. Palo Alto shares closed at $392.89 on Wednesday. See how other analysts view this stock.
- Compass Point analyst Floris Van Dijkum upgraded Pebblebrook Hotel Trust (NYSE:PEB) from Neutral to Buy and maintained the price target of $17. Pebblebrook Hotel shares closed at $12.37 on Wednesday. See how other analysts view this stock.
Considering buying PANW stock? Here's what analysts think:
Read This Next:
- Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 5% Dividend Yields